Wyeth Earnings Up on Demand for Key Drugs - Reuters - 23 Jul 2002
... quarterly earnings jumped on soaring sales of key medicines like antidepressant Effexor
and hemophilia treatment ReFacto. The Madison, New Jersey-based company ...

Pharmacia, Wyeth Report Strong Results - Smart Money - 23 Jul 2002
... sales grew 10% to $3.5 billion from $3.18 billion, bolstered by antidepressants
Effexor and Effexor XR and the ulcer drug Protonix. Monsanto Hurt by Exposure ...

Also:

Pharmacia, Wyeth Post Strong 2nd-Quarter Profits; Bristol-Myers ...  - Quicken Earnings Mixed for Drug Companies - Washington Post Copycats batter Bristol, Wyeth and Pharmacia shine - Forbes

Wyeth Earns Jump on Demand for Key Drugs - Reuters - 23 Jul 2002
... jumped 26 percent on soaring sales of key medicines like antidepressant Effexor and
hemophilia treatment ReFacto. The Madison, New Jersey-based company said it ...

Stocks Sell Off Again - Business Week - 23 Jul 2002
... quarterly earnings driven by strong sales of key products including antidepressant
Effexor. Hershey Foods posted 20% higher quarterly earnings on higher sales ...

Wyeth reports 26 percent increase in profit - Boston Globe - 23 Jul 2002
... by 13 percent, primarily due to higher sales of the anti-depression drug Effexor
XR. Net revenue of the company's health care products line increased by 1 ...

First step in beating depression is admitting it - CNN - 22 Jul 2002
... at CNN that he found a treatment that worked for him: talk therapy and the drug,
Effexor. "I don't want to suggest to anybody that it will work for them, but ...